Nanoprecise Closes US$38M Series C

Nanoprecise Closes US$38M Series C

Nanoprecise Secures US:38 million in Series C funding in a combined equity & debt round to make industrial maintenance smarter, faster, and more predictable EDMONTON, AB, March 27, 2025 /PRNewswire/ -- Nanoprecise Sci Corp is breaking the...

FlocCare secures US$500K to drive healthcare awareness and patient engagement with Gen AI

FlocCare secures US$500K to drive healthcare awareness and patient engagement with Gen AI

SINGAPORE, March 27, 2025 /PRNewswire/ -- Singapore-based B2B healthcare AI platform FlocCare Pte. Ltd. has just raised US$500K, with backing from DTVP, SDTA Ventures and prominent healthcare angel investors in Singapore. This funding will fuel...

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

LOS GATOS, Calif., March 26, 2025 /PRNewswire/ -- Supira Medical, Inc. (Supira), a clinical-stage Shifamed portfolio company, today announced the successful completion of an oversubscribed Series E financing round, raising $120M to accelerate the...

LG Energy Solution Secures Grid-scale ESS Supply Agreement in Europe with Poland's PGE

LG Energy Solution Secures Grid-scale ESS Supply Agreement in Europe with Poland's PGE

LG Energy Solution to supply 981MWh of grid-scale ESS batteries from 2026 to 2027 The company to deliver first grid-scale ESS batteries manufactured at its Poland facility SEOUL, South Korea, March 25, 2025 /PRNewswire/ -- LG Energy Solution...

FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

HONG KONG, March 24, 2025 /PRNewswire/ -- FuSure Reinsurance ("FuSure") is pleased to announce that, following four years of steady growth, it has successfully secured a long-term insurance authorization (Class A and Class D) from the Hong Kong...

GEP PROCUREMENT SOFTWARE SECURES THE TOP RANKING IN SPEND MATTERS SPRING 2025 SOLUTIONMAP, DOMINATING 12 CATEGORIES

GEP PROCUREMENT SOFTWARE SECURES THE TOP RANKING IN SPEND MATTERS SPRING 2025 SOLUTIONMAP, DOMINATING 12 CATEGORIES

Citing innovation, depth, and AI-driven intelligence, Spend Matters ranked GEP SMART as the highest-rated solution suite for the eighth consecutive report. GEP outscored 105 other solution providers in source-to-contract (S2C) suites, source-to-pay...

Sino Jet Secures Top Spot in Asia-Pacific Business Jet Fleet for the Sixth Consecutive Year, Five Strategic Pillars Set Industry Benchmark

Sino Jet Secures Top Spot in Asia-Pacific Business Jet Fleet for the Sixth Consecutive Year, Five Strategic Pillars Set Industry Benchmark

HONG KONG, March 19, 2025 /PRNewswire/ -- At the Business Aviation Asia Forum & Expo (BAAFEx) 2025, Asian Sky Group unveiled the Business Jet Fleet Report YE 2024, disclosing that the total number of business jets in the Asia-Pacific region had...

AirHelp Secures Significant Minority Investment from Abry Partners

AirHelp Secures Significant Minority Investment from Abry Partners

BERLIN, March 19, 2025 /PRNewswire/ -- AirHelp Inc. ("AirHelp"), the global leader in air passenger rights and compensation claims management, is excited to announce a significant minority investment from Abry Partners ("Abry"), a leading North...

Chance Pharma Secures New Funding to Accelerate Development of Innovative Inhalation Therapies

Chance Pharma Secures New Funding to Accelerate Development of Innovative Inhalation Therapies

HANGZHOU, China, March 17, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced the successful completion...

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

RAICHUR, India , March 12, 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug...

  • 1
  • 2
  • 3
  • 4
  • 5
  • menu
    menu